日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Pathogen-Specific Actinium-225 and Lutetium-177 Labeled Antibodies for Treatment of Biofilm-Associated Implant Infections: Initial In Vivo Proof-of-Concept

用于治疗生物膜相关植入物感染的病原体特异性锕-225和镥-177标记抗体：初步体内概念验证

期刊:Antibiotics-Basel
影响因子:4.6
doi:10.3390/antibiotics14121283
Nurmohamed, F Ruben H A; Allen, Kevin J H; Malo, Mackenzie E; Frank, Connor; van Duvenbode, J Fred F Hooning; van der Wildt, Berend; Poot, Alex J; Lam, Marnix G E H; van Strijp, Jos A G; Nikkels, Peter G J; Vogely, H Charles; Weinans, Harrie; Dadachova, Ekaterina; van der Wal, Bart C H
炎症/感染
微生物学
发表日期：2025
文献求助 收藏

Comparative In Vitro and In Vivo Evaluation of Anti-CCR8 Full-Sized IgG and Its Fab Fragments in Murine Colorectal Cancer Models

在小鼠结直肠癌模型中，对抗CCR8全长IgG及其Fab片段进行体外和体内比较评价

期刊:Molecules
影响因子:4.6
doi:10.3390/molecules30224445
Hu, Tongshuo; Jiao, Rubin; Allen, Kevin J H; Frank, Connor; Malo, Mackenzie E; Dadachova, Ekaterina
肿瘤
肠癌
肿瘤免疫
IgG
CCR8
发表日期：2025
文献求助 收藏

Correction to "In Vitro and In Vivo Comparison of Random versus Site-Specific Conjugation of Bifunctional Chelating Agents to the CD33-Binding Antibody for Use in Alpha- and Beta-Radioimmunotherapy"

对“用于α和β放射免疫疗法的双功能螯合剂与CD33结合抗体随机偶联和位点特异性偶联的体外和体内比较”一文的更正

期刊:ACS Omega
影响因子:4.3
doi:10.1021/acsomega.5c06157
Allen, Kevin J H; Frank, Connor; Jiao, Rubin; Malo, Mackenzie E; Bello, Michele; De Nardo, Laura; Meléndez-Alafort, Laura; Dadachova, Ekaterina
免疫/内分泌
CD3
CD33
发表日期：2025
文献求助 收藏

Fingolimod synergizes with anti-PD-1 radioimmunotherapy in an experimental multiple sclerosis model through enhanced lymph node retention and CD8(+) T cell depletion.

在实验性多发性硬化症模型中，芬戈莫德通过增强淋巴结滞留和 CD8(+) T 细胞耗竭，与抗 PD-1 放射免疫疗法产生协同作用

期刊:Frontiers in Medicine
影响因子:3
doi:10.3389/fmed.2025.1593933
Frank Connor, Allen Kevin J H, Dawicki Wojciech, Levin Michael C, Dadachova Ekaterina
细胞生物学
CD8
发表日期：2025
文献求助 收藏

In Vitro and In Vivo Comparison of Random versus Site-Specific Conjugation of Bifunctional Chelating Agents to the CD33-Binding Antibody for Use in Alpha- and Beta-Radioimmunotherapy.

体外和体内比较双功能螯合剂与 CD33 结合抗体随机偶联和位点特异性偶联在 α 和 β 放射免疫疗法中的应用

期刊:ACS Omega
影响因子:4.3
doi:10.1021/acsomega.4c09450
Allen Kevin J H, Frank Connor, Jiao Rubin, Malo Mackenzie E, Bello Michele, De Nardo Laura, Meléndez-Alafort Laura, Dadachova Ekaterina
免疫/内分泌
CD3
发表日期：2024
文献求助 收藏

Image-Based Dosimetry in Dogs and Cross-Reactivity with Human Tissues of IGF2R-Targeting Human Antibody

犬类图像剂量测定及靶向IGF2R的人源抗体与人组织的交叉反应性

期刊:Pharmaceuticals
影响因子:4.8
doi:10.3390/ph16070979
Allen, Kevin J H; Kwon, Ohyun; Hutcheson, Matthew R; Grudzinski, Joseph J; Cain, Stuart M; Cruz, Frederic A; Vinayakamoorthy, Remitha M; Sun, Ying S; Fairley, Lindsay; Prabaharan, Chandra B; Dickinson, Ryan; MacDonald-Dickinson, Valerie; Uppalapati, Maruti; Bednarz, Bryan P; Dadachova, Ekaterina
Human
发表日期：2023
文献求助 收藏

Comparative Molecular Characterization and Pharmacokinetics of IgG1-Fc and Engineered Fc Human Antibody Variants to Insulin-like Growth Factor 2 Receptor (IGF2R).

IgG1-Fc 和工程化 Fc 人源抗体变体与胰岛素样生长因子 2 受体 (IGF2R) 的比较分子特征和药代动力学

期刊:Molecules
影响因子:4.6
doi:10.3390/molecules28155839
Prabaharan Chandra B, Giri Sabeena, Allen Kevin J H, Bato Katrina E M, Mercado Therese R, Malo Mackenzie E, Carvalho Jorge L C, Dadachova Ekaterina, Uppalapati Maruti
免疫/内分泌
Human
IGG1
IgG
发表日期：2023
文献求助 收藏

Targeting Melanin in Melanoma with Radionuclide Therapy

利用放射性核素疗法靶向黑色素瘤中的黑色素

期刊:International Journal of Molecular Sciences
影响因子:4.9
doi:10.3390/ijms23179520
Allen, Kevin J H; Malo, Mackenzie E; Jiao, Rubin; Dadachova, Ekaterina
黑色素瘤
发表日期：2022
文献求助 收藏

Radioimmunotherapy Targeting IGF2R on Canine-Patient-Derived Osteosarcoma Tumors in Mice and Radiation Dosimetry in Canine and Pediatric Models

放射免疫疗法靶向治疗犬源性骨肉瘤肿瘤中的IGF2R，并在犬和儿童模型中进行放射剂量测定

期刊:Pharmaceuticals
影响因子:4.8
doi:10.3390/ph15010010
Broqueza, Jaline; Prabaharan, Chandra B; Allen, Kevin J H; Jiao, Rubin; Fisher, Darrell R; Dickinson, Ryan; MacDonald-Dickinson, Valerie; Uppalapati, Maruti; Dadachova, Ekaterina
Canine
发表日期：2021
文献求助 收藏

Safety Evaluation of an Alpha-Emitter Bismuth-213 Labeled Antibody to (1→3)-β-Glucan in Healthy Dogs as a Prelude for a Trial in Companion Dogs with Invasive Fungal Infections

在健康犬中对α发射体铋-213标记的抗(1→3)-β-葡聚糖抗体进行安全性评估，作为在患有侵袭性真菌感染的伴侣犬中进行试验的先导研究

期刊:Molecules
影响因子:4.6
doi:10.3390/molecules25163604
Helal, Muath; Allen, Kevin J H; Burgess, Hilary; Jiao, Rubin; Malo, Mackenzie E; Hutcheson, Matthew; Dadachova, Ekaterina; Snead, Elisabeth
炎症/感染
微生物学
发表日期：2020
文献求助 收藏